RPG Life Sciences Ltd
Denosumab (60mg/ml)
Denbri Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures.
Injection
Denbri Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong and reduce the risk of fractures.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
No common side effects listed.
Caution is advised when consuming alcohol with Denbri Injection. Please consult your doctor.
Denbri Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Denbri Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Denbri Injection is a monoclonal antibody. It binds to a protein that causes bone loss thereby strengthening the bone and minimizing the risk of fractures.
Denbri Injection is a medication used to treat thinning of the bones (called osteoporosis). Take calcium and vitamin D to help build your bones when taking Denbri Injection. Do not take if you are pregnant or plan to become pregnant. May cause a rare problem of the jaw (osteonecrosis) mostly seen after a dental procedure. Tell your doctor if you develop sudden jaw pain. Denbri Injection may also increase the risk of infection. Avoid being close to people with cold flu or other contagious illnesses.